CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours

G. Pelosi, Filippo Fraggetta, Angelica Sonzogni, Nicola Fazio, Alessandra Cavallon, Giuseppe Viale

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Although considered a specific marker for Ewing's sarcoma/peripheral neuroectodermal tumour, the MIC2 gene product (CD99) has been immunolocalised in a variety of human tumours. The present study evaluated immunohistochemically the prevalence of CD99 expression in a series of 68 neuroendocrine tumours of different gastrointestinal and pulmonary sites. We now report on membrane and/or granular cytoplasmic immunoreactivity in 25% of these tumours, independent of their anatomical sites. In lung neuroendocrine tumours, CD99 was preferentially confined to typical carcinoids (P=0.009). A statistically significant relationship was observed between the number of CD99 positive cells but not the immunostaining patterns and the presence of local invasion and/or distant metastases (P

Original languageEnglish
Pages (from-to)270-274
Number of pages5
JournalVirchows Archiv
Volume437
Issue number3
DOIs
Publication statusPublished - 2000

Fingerprint

Neuroendocrine Tumors
Peripheral Primitive Neuroectodermal Tumors
Lung
Ewing's Sarcoma
Carcinoid Tumor
Neoplasms
Neoplasm Metastasis
Membranes
Genes

Keywords

  • CD99 antigen
  • Cell-to-cell adhesion
  • Immunohistochemistry
  • Neuroendocrine tumours
  • Proliferative activity

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours. / Pelosi, G.; Fraggetta, Filippo; Sonzogni, Angelica; Fazio, Nicola; Cavallon, Alessandra; Viale, Giuseppe.

In: Virchows Archiv, Vol. 437, No. 3, 2000, p. 270-274.

Research output: Contribution to journalArticle

@article{5b07f6edfcb741fba986d0bf8726dac7,
title = "CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours",
abstract = "Although considered a specific marker for Ewing's sarcoma/peripheral neuroectodermal tumour, the MIC2 gene product (CD99) has been immunolocalised in a variety of human tumours. The present study evaluated immunohistochemically the prevalence of CD99 expression in a series of 68 neuroendocrine tumours of different gastrointestinal and pulmonary sites. We now report on membrane and/or granular cytoplasmic immunoreactivity in 25{\%} of these tumours, independent of their anatomical sites. In lung neuroendocrine tumours, CD99 was preferentially confined to typical carcinoids (P=0.009). A statistically significant relationship was observed between the number of CD99 positive cells but not the immunostaining patterns and the presence of local invasion and/or distant metastases (P",
keywords = "CD99 antigen, Cell-to-cell adhesion, Immunohistochemistry, Neuroendocrine tumours, Proliferative activity",
author = "G. Pelosi and Filippo Fraggetta and Angelica Sonzogni and Nicola Fazio and Alessandra Cavallon and Giuseppe Viale",
year = "2000",
doi = "10.1007/s004280000240",
language = "English",
volume = "437",
pages = "270--274",
journal = "Virchows Archiv - A Pathological Anatomy and Histopathology",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours

AU - Pelosi, G.

AU - Fraggetta, Filippo

AU - Sonzogni, Angelica

AU - Fazio, Nicola

AU - Cavallon, Alessandra

AU - Viale, Giuseppe

PY - 2000

Y1 - 2000

N2 - Although considered a specific marker for Ewing's sarcoma/peripheral neuroectodermal tumour, the MIC2 gene product (CD99) has been immunolocalised in a variety of human tumours. The present study evaluated immunohistochemically the prevalence of CD99 expression in a series of 68 neuroendocrine tumours of different gastrointestinal and pulmonary sites. We now report on membrane and/or granular cytoplasmic immunoreactivity in 25% of these tumours, independent of their anatomical sites. In lung neuroendocrine tumours, CD99 was preferentially confined to typical carcinoids (P=0.009). A statistically significant relationship was observed between the number of CD99 positive cells but not the immunostaining patterns and the presence of local invasion and/or distant metastases (P

AB - Although considered a specific marker for Ewing's sarcoma/peripheral neuroectodermal tumour, the MIC2 gene product (CD99) has been immunolocalised in a variety of human tumours. The present study evaluated immunohistochemically the prevalence of CD99 expression in a series of 68 neuroendocrine tumours of different gastrointestinal and pulmonary sites. We now report on membrane and/or granular cytoplasmic immunoreactivity in 25% of these tumours, independent of their anatomical sites. In lung neuroendocrine tumours, CD99 was preferentially confined to typical carcinoids (P=0.009). A statistically significant relationship was observed between the number of CD99 positive cells but not the immunostaining patterns and the presence of local invasion and/or distant metastases (P

KW - CD99 antigen

KW - Cell-to-cell adhesion

KW - Immunohistochemistry

KW - Neuroendocrine tumours

KW - Proliferative activity

UR - http://www.scopus.com/inward/record.url?scp=0033825878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033825878&partnerID=8YFLogxK

U2 - 10.1007/s004280000240

DO - 10.1007/s004280000240

M3 - Article

VL - 437

SP - 270

EP - 274

JO - Virchows Archiv - A Pathological Anatomy and Histopathology

JF - Virchows Archiv - A Pathological Anatomy and Histopathology

SN - 0945-6317

IS - 3

ER -